IFC Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
3,192
-3
-0.1% -$1.44K 0.2% 74
2026
Q1
$1.57M Sell
3,195
-61
-2% -$33.1K 0.22% 69
2025
Q4
$1.89M Buy
3,256
+2
+0.1% +$1.13K 0.28% 63
2025
Q3
$1.58M Buy
3,254
+67
+2% +$31.2K 0.29% 70
2025
Q2
$1.29M Sell
3,187
-28
-0.9% -$11.7K 0.24% 81
2025
Q1
$1.6M Sell
3,215
-37
-1% -$20K 0.33% 64
2024
Q4
$1.69M Buy
+3,252
New +$1.79M 0.37% 55

Other funds holding TMO

IFC Advisors's TMO Position: Q2 2026 in Review

IFC Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.09% in Q2 2026, selling an estimated $1.44K and leaving 3,192 shares worth $1.6M. The position accounts for 0.2% of the portfolio, ranked #74.

IFC Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.89M in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • IFC Advisors held 3,192 shares of Thermo Fisher Scientific worth $1.6M as of Q2 2026.
  • IFC Advisors sold 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.2% of IFC Advisors's portfolio in Q2 2026, its #74 holding.
  • IFC Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • IFC Advisors's Thermo Fisher Scientific position peaked at $1.89M in Q4 2025.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on IFC Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.